Julia G. Butchko Immunovant, Inc. (IMVT) insider trading activity

Julia G. Butchko is Chief Development Officer of Immunovant, Inc.. Currently has a direct ownership of 448,380 shares of IMVT, which is worth approximately $12.3 Million. The most recent transaction as insider was on May 22, 2024, when has been sold 3,247 shares (Common Stock) at a price of $29.65 per share, resulting in proceeds of $96,273. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 448K

3.11% 3M change

4.26% 12M change

Total Value Held $12.3 Million

Julia G. Butchko Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 22 2024	SELL Open market or private sale	$96,273 $29.65 p/Share	3,247 Reduced 0.72%	448,380 Common Stock
Apr 17 2024	SELL Open market or private sale	$297,077 $29.37 p/Share	10,115 Reduced 2.19%	451,627 Common Stock
Apr 09 2024	SELL Open market or private sale	$32,832 $31.18 p/Share	1,053 Reduced 0.23%	461,742 Common Stock
Apr 02 2024	BUY Grant, award, or other acquisition	-	54,978 Added 10.62%	462,795 Common Stock
Feb 22 2024	SELL Open market or private sale	$77,577 $36.15 p/Share	2,146 Reduced 0.52%	407,817 Common Stock
Jan 05 2024	SELL Open market or private sale	$50,051 $38.59 p/Share	1,297 Reduced 0.32%	409,963 Common Stock
Nov 22 2023	SELL Open market or private sale	$108,202 $33.14 p/Share	3,265 Reduced 0.79%	411,260 Common Stock

Oct 05 2023	SELL Open market or private sale	$62,407 $35.97 p/Share	1,735 Reduced 0.42%	414,525 Common Stock
Aug 24 2023	SELL Open market or private sale	$253,936 $20.59 p/Share	12,333 Reduced 2.88%	416,260 Common Stock
Jul 12 2023	SELL Open market or private sale	$29,003 $19.73 p/Share	1,470 Reduced 0.34%	428,593 Common Stock
Apr 18 2023	SELL Open market or private sale	$23,576 $15.27 p/Share	1,544 Reduced 0.36%	430,063 Common Stock
Apr 12 2023	BUY Grant, award, or other acquisition	-	100,188 Added 18.84%	431,607 Common Stock
Jan 11 2023	SELL Open market or private sale	$966,630 $15.98 p/Share	60,490 Reduced 15.43%	331,419 Common Stock
Oct 13 2022	SELL Open market or private sale	$8,519 $9.18 p/Share	928 Reduced 0.24%	391,909 Common Stock
Sep 28 2022	SELL Open market or private sale	$2,498 $4.67 p/Share	535 Reduced 0.14%	392,837 Common Stock
Aug 30 2022	SELL Open market or private sale	$3,195 $5.83 p/Share	548 Reduced 0.14%	393,372 Common Stock
Aug 17 2022	BUY Grant, award, or other acquisition	-	112,816 Added 22.26%	393,920 Common Stock
Jul 27 2022	SELL Open market or private sale	$2,178 $4.27 p/Share	510 Reduced 0.18%	281,104 Common Stock
Jun 29 2022	SELL Open market or private sale	$1,849 $4.02 p/Share	460 Reduced 0.16%	281,614 Common Stock
May 24 2022	SELL Open market or private sale	$1,865 $3.79 p/Share	492 Reduced 0.17%	282,074 Common Stock
Apr 27 2022	SELL Open market or private sale	$2,554 $4.72 p/Share	541 Reduced 0.19%	282,566 Common Stock
Mar 24 2022	SELL Open market or private sale	$37,648 $5.9 p/Share	6,381 Reduced 2.2%	283,107 Common Stock
Jan 07 2022	SELL Open market or private sale	$401,056 $7.25 p/Share	55,318 Reduced 16.04%	289,488 Common Stock
Aug 03 2021	BUY Grant, award, or other acquisition	-	285,306 Added 45.28%	344,806 Common Stock
Mar 19 2021	BUY Grant, award, or other acquisition	-	54,500 Added 47.81%	59,500 Common Stock

JGB

Julia G. Butchko

Chief Development Officer

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Value

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Immunovant, Inc.

Track Activities on IMVT

Account